Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Toniutto, Pierluigi
DHELIVER, NCT04229901: Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF)	Terminated	2	133	Europe, RoW	HepaStem, Placebo	Cellaion SA	Acute on Chronic Liver Failure	05/24	05/24
HDV Describe, NCT05723068: Burden of Hepatitis D Virus (HDV) Infection in Italy	Completed	N/A	515	Europe		University of Turin, Italy, Gilead Sciences	Chronic Hepatitis D	06/24	12/24
Bignulin, Sara
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Toniutto, Pierluigi
DHELIVER, NCT04229901: Study to Evaluate the Efficacy and Safety of HepaStem in Patients With Acute on Chronic Liver Failure (ACLF)	Terminated	2	133	Europe, RoW	HepaStem, Placebo	Cellaion SA	Acute on Chronic Liver Failure	05/24	05/24
HDV Describe, NCT05723068: Burden of Hepatitis D Virus (HDV) Infection in Italy	Completed	N/A	515	Europe		University of Turin, Italy, Gilead Sciences	Chronic Hepatitis D	06/24	12/24
Bignulin, Sara
No trials found